PBE ETF (Invesco Biotechnology and Genome ETF) is managed by Invesco (US) with $282.8M in net assets. PBE expense ratio is 0.58%, holding 33 positions across sectors including Health Care, Unknown, Financials. Inception date: 2005-06-23.

PBE performance shows a YTD return of 10.00%. The 1-year return is 42.47% and the 5-year return is 3.45%. PBE dividend yield stands at 1.73%, paid quarterly.

PBE top holdings include Nvaesrtex Pharmaceuticals Inc (5.2%), Biogen Inc. Com (5.1%), Amgen, Inc. (4.9%), Rpi International Holdings Lp P/P (4.8%), Regeneron Pharmaceuticals, Inc. (4.5%). View all PBE holdings, sector breakdown, or dividend history.

PBE can be compared against other funds using the overlap calculator or side-by-side comparison tool. PBE alternatives are available via the screener, along with tax-loss harvesting opportunities.